Chimeric natriuretic peptides

Details Chimeric natriuretic peptides Chimeric natriuretic peptides

2011-06-21

2011-06-21

Robinson, Hope A (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S350000, C435S006120

Reexamination Certificate

active

07964564

ABSTRACT:
Peptides ofDendroaspis, including chimeric peptides thereof, are provided, as well as methods of using the peptides as natriuretics, diuretics, and/or vasodilators.

REFERENCES:
patent: 3842067 (1974-10-01), Sarantakis
patent: 3862925 (1975-01-01), Sarantakis et al.
patent: 3972859 (1976-08-01), Fujino et al.
patent: 4051842 (1977-10-01), Hazel et al.
patent: 4105602 (1978-08-01), Colescott et al.
patent: 4140122 (1979-02-01), Kuhl et al.
patent: 4161521 (1979-07-01), Veber et al.
patent: 4383529 (1983-05-01), Webster
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4757048 (1988-07-01), Lewicki et al.
patent: 4804650 (1989-02-01), Lewicki et al.
patent: 4935492 (1990-06-01), Lewicki et al.
patent: 5047397 (1991-09-01), Scarborough et al.
patent: 5114923 (1992-05-01), Seilhamer et al.
patent: 5202239 (1993-04-01), Tarnowski et al.
patent: 5322930 (1994-06-01), Tarnowski et al.
patent: 5560922 (1996-10-01), Chien et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5583108 (1996-12-01), Wei et al.
patent: 5674710 (1997-10-01), Seilhamer et al.
patent: 5691310 (1997-11-01), Vesely
patent: 5848956 (1998-12-01), Grettner
patent: 5948761 (1999-09-01), Seilhamer et al.
patent: 6124430 (2000-09-01), Mischak et al.
patent: 6162902 (2000-12-01), Mischak et al.
patent: 6407211 (2002-06-01), Burnett, Jr. et al.
patent: 6818619 (2004-11-01), Burnett, Jr. et al.
patent: 7384917 (2008-06-01), Burnett et al.
patent: 0 045 665 (1985-09-01), None
patent: WO 93/02556 (1993-02-01), None
patent: WO 99/12576 (1999-03-01), None
patent: WO 00/71576 (2000-11-01), None
Abdallah et al., “Non-viral gene transfer: Applications in developmental biology and gene therapy,”Biol. Cell, 1995, 85:1-7.
Adelman et al., “In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone,”DNA, 1983, 2(3):183-193.
Almquist et al., “Synthesis and Biological Activity of a Ketomethylene Analogue of a Tripeptide Inhibitor of Angiotensin Converting Enzyme,”J. Med. Chem., 1980, 23:1392-1398.
Atlas and Laragh, “Physiological Actions of Atrial Natriuretic Factor,”Atrial Hormones and Other Natriuretic Factors, 1987, Mulrow et al. (eds.), Am. Physiol. Soc., Bethesda, MD, pp. 53-76.
Brenner et al., “Diverse Biological Actions of Atrial Natriuretic Peptide,”Physiol. Rev., 1990, 70:665-699.
Bruneau et al., “BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria,”Am. J. Physiol., 1997, 273:H2678-H2686.
Burnett, Jr. et al., “Atrial Natriutetic Peptide Elevation in Congestive Heart Failure in the Human,”Science, 1986, 231:1145-1147.
Burnett, Jr. et al., “Effects of synthetic atrial natriuretic factor on renal function and renin release,”Am. J. Physiol.: Renal Phy., 1984, 247(5 PT 2):F863-F866.
Carpino and Han, “The 9-Fluorenylmethoxycarbonyl Amino-Protecting Group,”J. Org. Chem., 1972, 37(22):3404-3409.
Cavero et al., “Cardiorenal Actions of Neutral Endopeptidase Inhibition in Experimental Congestive Heart Failure,”Circulation, 1990, 82:196-201.
Clavell et al., “Biological actions of brain natriuretic peptide in thoracic inferior vena caval constriction,”Am. J. Physiol., 1993, 265:R1416-R1422.
Crea et al., “Chemical synthesis of genes for human insulin,”Proc. Natl. Acad. Sci. USA, 1978, 75(12):5765-5769.
Barker and Dayhoff, “Detecting Distant Relationships: Computer Methods and Results,”Atlas of Protein Sequence and Structure, 1972, vol. 5, National Biomedical Research Foundation, pp. 101-110.
de Bold et al., “A Rapid and Potent Natriuretic Response to Intravenous Injection of Atrial Myocardial Extract in Rats,”Life Sci., 1981, 28:89-94.
Donnelly et al., “Protective Efficacy of Intramuscular Immunization with Naked DNA,”Ann. N.Y. Acad. Sci., 1995, 772:40-46.
Edwards et al., “Atrial Stretch, Not Pressure, Is the Principal Determinant Controlling the Acute Release of Atrial Natriuretic Factor,”Circ. Res., 1988, 62:191-195.
Flynn et al., “The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties,”Biochem. Biophys. Res. Commun., 1983, 117(3):859-865.
Girbes et al., “Renal Function Is the Most Important Determinant of Survival in Patients With Severe Congestive Heart Failure,”J. Am. Coll. Cardiol., 1998, 31:154A.
Goeddel et al., “Synthesis of human fibroblast interferon byE. coli,” Nucl. Acids Res., 1980, 8(19):40157-4074.
Grantham and Burnett, Jr., “Natriuretic Peptides in Cardiovascular Disease,”Natriuretic Peptides in Health and Disease, 1997, Samson and Levin (eds.), Humana Press, pp. 309-326.
Guo et al., “Protein tolerance to random amino acid change,”Proc. Natl. Acad. Sci. USA, 2004, 101(25):9205-9210.
Cullen et al., “Crystal and Molecular Structure of a 4,5-Dimethyoxbilindione derived from Etiobiliverdin-IVγ: a Possible Model Compound for the Phytochrome Chromophore,”J. Chem. Soc. Perkin Trans., 1982, 1:307-312.
Holladay and Rich, “Synthesis of Hydroxyethylene and Ketomethylene Dipeptide Isosteres,”Tetrahedron Lett., 1983, 24(41):4401-4404.
Hruby, “Conformational Restrictions of Biologically Active Peptides Via Amino Acid Side Chain Groups,”Life Sci., 1982, 31:189-199.
Hudson et al., “Methionine Enkephalin 14:177-185 and Isosteric Analogues,”Int. J. Peptide Protein Res., 1979, 14:177-185.
Huntley et al., “BNP-Induced Activation of cGMP in Human Cardiac Fibroblasts: Interactions with Fibronectin and Natriuretic Peptide Receptors,”J. Cell. Physiol., 2006, 209:943-949.
Jennings-White and Almquist, “Synthesis of Ketomethylene Analogs of Dipeptides,”Tetrahedron Lett., 1982, 23:2533-2534.
Kambayashi et al., “Isolation and sequence determination of human brain natriuretic peptide in human atrium,”FEBS Lett., 1990, 259(2):341-345.
Koller et al., “Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP),”Science, 1991, 252:120-123.
Lawn et al., “The sequence of human serum albumin cDNA and its expression inE. coli,” Nucl. Acids Res., 1981, 9(22):6103-6114.
Lebl and Hruby, “Synthesis of Cyclic Peptides by Solid Phase Methodology,”Tetrahedron Lett., 1984, 25(20):2067-2067.
Lin et al., “Human Atrial Natriuretic Peptide Gene Delivery Reduces Blood Pressure in Hypertensive Rats,”Hypertension, 1995, 26:847-853.
Lisy et al., “A New Natriuretic Peptide Present in Canine Plasma and Heart,”J. Cardiac Failure, 1998, 4(3), Suppl. 1, Abstract No. Y3, p. 1.
Lisy et al., “Renal actions of syntheticDendroaspisnatriuretic peptide,”Kidney International, 1999, 56:502-508.
Lisy et al., “Therapeutic Action of a New Natriuretic and Vasoactive Peptide DNP in Experimental Severe Congestive Heart Failure,”Circulation, 1999, 100(18) Supplement 1, Abstract No. 3354, pp. 1-636.
Lisy et al., “Therapeutic Actions of a New Synthetic Vasoactive and Natriuretic Peptide, Dendroaspis Natriuretic Peptide, in Experimental Severe Congestive Heart Failure,”Hypertension, 2001, 37(4):1089-1094.
Lisy et al., “Unique Renal and Systemic Hemodynamic Actions of a New Natriuretic Peptide in Experimental Heart Failure,”JACC, 1999, Abstract No. 1199-17, p. 202A.
McDonagh et al., “Biochemical detection of left-ventricular systolic dysfunction,”Lancet, 1998, 351:9-13.
Meienhofer, “Peptide Synthesis: A Review of the Solid-Phase Method,”Hormonal Proteins and Peptides, 1973, vol. 2, Li (ed.), Academic Press, pp. 45-267.
Chang and Meienhofer, “Solid-Phase Peptide Synthesis Using Mild Base Cleavage of Nα-Fluorenymethyloxycarbonylamino Acids, Exemplified by a Synthesisof Dihydrosomastatin,”Int. J. Peptide Protein Res., 1978, 11:246-249.
Merrifield, “

Affiliated with

Also associated with

Rating

Chimeric natriuretic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chimeric natriuretic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chimeric natriuretic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2629135